Stable expression of both the LEDGF-IBD, a peptide that lacks the chromatin binding domain, and a siRNA targeting LEDGF inhibited HIV infection in human cell lines and CD4+ T cells by 40-fold [52]. This evidence concerns the gene PSIP1 and HIV infectious disease.